Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 10.40% vs 22.63% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is 202.73% vs -772.91% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 33.02% vs 50.74% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is -42.13% vs 49.36% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
Compare Quarterly Results Of Astellas Pharma, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 8.94% vs 3.66% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 10.40% vs 22.63% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 26.65% vs 15.77% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 202.73% vs -772.91% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 12.20% vs -1.51% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 33.02% vs 50.74% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is -9.17% vs -54.34% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -42.13% vs 49.36% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






